Terrascend Corp TRSSF reported first-quarter revenue of CA$14.6 million ($10.8 million) Thursday and reiterated its full-year guidance.
What Happened
The cannabis company said its revenue surged higher from CA$5 million in the fourth quarter.
TerraAscend had zero revenue in the first quarter of 2018.
TerrAscend's adjusted EBITDA loss of CA$7.2 million is higher than its CA$7.1-million loss in the prior quarter and its CA$1.6-million loss in the same period in 2018.
The net first-quarter loss of CA 26 cents per share is wider than the CA 2-cent loss per share a year earlier.
The company ended March with CA$8.6 million in cash and cash equivalents.
Why It's Important
TerrAscend has scaled operations in both Canada and the U.S. During the first quarter, the company said it posted CA$5.7 million in sales of hemp-derived CBD products in the U.S.
In February, TerrAscend announced the establishment of an American retail footprint through the acquisition of Apothecarium, a multistate dispensary operator with locations in California and Nevada.
The acquisition also includes Valhalla Confections, a manufacturer of edible products.
What's Next
TerrAscend is in the process of completing the acquisition of Apothecarium.
The company expects to start distribution of products in Germany after having received a GMP certificate for its Mississauga, Ontario facility.
TerrAscend said it expects full-year revenue of more than CA$135 million.
Related Links:
Discussing Sol Global's $30M Hemp Biomass Investment With CEO Brady Cobb
Tilray Boosts Export Capability With EU Manufacturing License, GMP Certification
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.